FEMSelect develops women’s-health medical devices for pelvic floor conditions, notably EnPlace, a mesh-free system for minimally invasive, same-day pelvic organ prolapse repair. The company grew from POP Medical Solutions, which began developing the technology in 2013, received FDA clearance in 2016, and changed its name to FEMSelect in 2019. FEMSelect is woman-led and also offers FDA-cleared Elitone devices for at-home urinary-incontinence treatment.
CE Mark
certification
FDA 510(k) Clearance
registration